Connection

David Boutolleau to Antiviral Agents

Back to Details
This is a "connection" page, showing publications David Boutolleau has written about Antiviral Agents.
David Boutolleau
Connection Strength
0.155
Antiviral Agents
  1. Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19. J Infect. 2021 01; 82(1):159-198.
    View in: PubMed
    Score: 0.082
  2. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations. Antiviral Res. 2018 03; 151:20-23.
    View in: PubMed
    Score: 0.017
  3. Antiviral effects of Cacicol®, a heparan sulfate biomimetic for corneal regeneration therapy, for herpes simplex virus type-1 and varicella zoster virus infection. Antivir Ther. 2018; 23(8):665-675.
    View in: PubMed
    Score: 0.017
  4. A European multi-centre External Quality Assessment (EQA) study on phenotypic and genotypic methods used for Herpes Simplex Virus (HSV) drug resistance testing. J Clin Virol. 2017 11; 96:89-93.
    View in: PubMed
    Score: 0.017
  5. Recurrent herpetic keratitis despite antiviral prophylaxis: A virological and pharmacological study. Antiviral Res. 2017 Oct; 146:205-212.
    View in: PubMed
    Score: 0.017
  6. Clinical management of respiratory syndrome in patients hospitalized for suspected Middle East respiratory syndrome coronavirus infection in the Paris area from 2013 to 2016. BMC Infect Dis. 2018 07 16; 18(1):331.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.